# Uranium Energy Corp: overview

UEC · NYSE · CIK 1334933 · [Materials](/sectors/materials.md) · fiscal year ends Jul 31

Pages: [Overview](/companies/uec.md) · [Financials](/companies/uec/financials.md) · [Filings](/companies/uec/filings.md) · [Insiders](/companies/uec/insiders.md)

Latest reported revenue: [$17.1m](/filings/0001437749-26-031414.md) for Q4 FY2026, three months to 2026-07-31, from the 10-K filed Sep 29, 2026 (XBRL us-gaap:Revenues, accession 0001437749-26-031414).

## Last eight quarters

| Line item | Unit | Q1 FY2025 (2024-10-31) | Q2 FY2025 (2025-01-31) | Q3 FY2025 (2025-04-30) | Q4 FY2025 (2025-07-31) | Q1 FY2026 (2025-10-31) | Q2 FY2026 (2026-01-31) | Q3 FY2026 (2026-04-30) | Q4 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [17.1](/filings/0001437749-25-037296.md) | [49.8](/filings/0001437749-26-007413.md) | [0.0](/filings/0001437749-26-019889.md) | [0.0 d](/filings/0001437749-26-031414.md) | [0.0](/filings/0001437749-25-037296.md) | [20.2](/filings/0001437749-26-007413.md) | [0.0](/filings/0001437749-26-019889.md) | [17.1 d](/filings/0001437749-26-031414.md) |
| Gross margin | % | [36.6%](/filings/0001437749-25-037296.md) | [36.6%](/filings/0001437749-26-007413.md) | not reported | not reported | not reported | [49.6%](/filings/0001437749-26-007413.md) | not reported | [40.3% d](/filings/0001437749-26-031414.md) |
| Operating margin | % | [(77.3%)](/filings/0001437749-25-037296.md) | [(7.3%)](/filings/0001437749-26-007413.md) | not reported | not reported | not reported | [(116.6%)](/filings/0001437749-26-007413.md) | not reported | [(228.6%) d](/filings/0001437749-26-031414.md) |
| Net margin | % | [(118.0%)](/filings/0001437749-26-019889.md) | [(20.6%)](/filings/0001437749-26-019889.md) | not reported | not reported | not reported | [(69.0%)](/filings/0001437749-26-019889.md) | not reported | [(355.9%) d](/filings/0001437749-26-031414.md) |
| Diluted EPS | $ per share | [(0.05)](/filings/0001437749-25-037296.md) | [(0.02)](/filings/0001437749-26-007413.md) | [(0.07)](/filings/0001437749-26-019889.md) | not reported | [(0.02)](/filings/0001437749-25-037296.md) | [(0.03)](/filings/0001437749-26-007413.md) | [(0.11)](/filings/0001437749-26-019889.md) | not reported |
| Free cash flow | $m | [(12.7)](/filings/0001437749-25-037296.md) | [(10.0) d](/filings/0001437749-26-007413.md) | [(22.8) d](/filings/0001437749-26-019889.md) | [(24.4) d](/filings/0001437749-26-031414.md) | [(35.4)](/filings/0001437749-25-037296.md) | [(39.1) d](/filings/0001437749-26-007413.md) | [(21.3) d](/filings/0001437749-26-019889.md) | [(11.6) d](/filings/0001437749-26-031414.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure.

## Last five fiscal years

| Line item | Unit | FY2022 (2022-07-31) | FY2023 (2023-07-31) | FY2024 (2024-07-31) | FY2025 (2025-07-31) | FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [23.2](/filings/0001437749-24-030107.md) | [164](/filings/0001437749-25-029761.md) | [0.2](/filings/0001437749-26-031414.md) | [66.8](/filings/0001437749-26-031414.md) | [37.3](/filings/0001437749-26-031414.md) |
| Gross margin | % | [31.5%](/filings/0001437749-24-030107.md) | [30.2%](/filings/0001437749-25-029761.md) | [16.5%](/filings/0001437749-26-031414.md) | [36.6%](/filings/0001437749-26-031414.md) | [45.4%](/filings/0001437749-26-031414.md) |
| Operating margin | % | [(98.1%)](/filings/0001437749-24-030107.md) | [5.4%](/filings/0001437749-25-029761.md) | [(25179.5%)](/filings/0001437749-26-031414.md) | [(109.7%)](/filings/0001437749-26-031414.md) | [(357.4%)](/filings/0001437749-26-031414.md) |
| Net margin | % | [22.7%](/filings/0001437749-24-030107.md) | [(2.0%)](/filings/0001437749-25-029761.md) | [(13045.1%)](/filings/0001437749-26-031414.md) | [(131.1%)](/filings/0001437749-26-031414.md) | [(368.6%)](/filings/0001437749-26-031414.md) |
| Diluted EPS | $ per share | [0.02](/filings/0001437749-24-030107.md) | [(0.01)](/filings/0001437749-25-029761.md) | [(0.07)](/filings/0001437749-26-031414.md) | [(0.20)](/filings/0001437749-26-031414.md) | [(0.28)](/filings/0001437749-26-031414.md) |
| Free cash flow | $m | [(53.6)](/filings/0001437749-24-030107.md) | [72.0](/filings/0001437749-25-029761.md) | [(108)](/filings/0001437749-26-031414.md) | [(69.9)](/filings/0001437749-26-031414.md) | [(107)](/filings/0001437749-26-031414.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/uec/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $432.7m | 40,588,755 |  | Added +3,081,664 |
| [MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.](/funds/1705339.md) | 2026-06-30 | $369.9m | 34,695,667 |  | Added +593,527 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $335.9m | 31,505,295 |  | Added +6,307,598 |
| [VAN ECK ASSOCIATES CORP](/funds/869178.md) | 2026-06-30 | $309.5m | 29,034,465 |  | Added +5,191,738 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $255.4m | 23,958,702 |  | Added +627,913 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $235.7m | 22,115,075 |  | Added +476,671 |
| [NORGES BANK](/funds/1374170.md) | 2026-06-30 | $186.5m | 17,499,619 |  | New +17,499,619 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $132.2m | 12,394,907 |  | Reduced −317,258 |
| [ALPS ADVISORS INC](/funds/1376113.md) | 2026-06-30 | $104.8m | 9,829,329 |  | Added +354,545 |
| [ALLIANCEBERNSTEIN L.P.](/funds/1109448.md) | 2026-06-30 | $85.5m | 6,331,128 |  | Reduced −580,703 |

## Recent filings

[All 1,398 filings](/companies/uec/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-29 | 10:00 ET | [8-K](/filings/0001437749-26-031416.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-031416 |
| 2026-09-29 | 01:39 ET | [10-K](/filings/0001437749-26-031414.md) | Annual report, period 2026-07-31 | 0001437749-26-031414 |
| 2026-07-28 | 19:15 ET | [SCHEDULE 13D](/filings/0001437749-26-024641.md) | Ownership report, active investor | 0001437749-26-024641 |
| 2026-07-23 | 20:41 ET | [8-K](/filings/0001437749-26-024336.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-024336 |
| 2026-06-10 | 00:15 ET | [DEF 14A](/filings/0001437749-26-020059.md) | Proxy statement, period 2026-07-23 | 0001437749-26-020059 |
| 2026-06-09 | 21:00 ET | [8-K](/filings/0001437749-26-020021.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-020021 |
| 2026-06-09 | 00:31 ET | [10-Q](/filings/0001437749-26-019889.md) | Quarterly report, period 2026-04-30 | 0001437749-26-019889 |
| 2026-05-28 | 20:30 ET | [8-K](/filings/0001437749-26-018759.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-018759 |
| 2026-05-01 | 21:15 ET | [SCHEDULE 13D/A](/filings/0001437749-26-014509.md) | Ownership report, active investor, amended | 0001437749-26-014509 |
| 2026-04-08 | 20:30 ET | [8-K](/filings/0001437749-26-011769.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-011769 |

## Latest annual report

[Form 10-K for the fiscal year ended Jul 31, 2026](/filings/0001437749-26-031414.md), filed Sep 29, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1334933
- Tickers: UEC
- Exchange: NYSE
- SIC code: 1090 Miscellaneous Metal Ores
- State of incorporation: NV
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.